Mike Kratky
Stock Analyst at Leerink Partners
(4.36)
# 1,305
Out of 4,994 analysts
269
Total ratings
46.2%
Success rate
13.2%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Buy | $28 → $27 | $22.81 | +18.37% | 6 | Sep 17, 2026 | |
| PODD Insulet | Downgraded: Hold | $355 → $145 | $139.38 | +4.03% | 16 | Aug 6, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $74 → $60 | $44.92 | +33.57% | 9 | Jul 30, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $87 → $101 | $88.78 | +13.76% | 32 | Jul 24, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $600 → $454 | $402.09 | +12.91% | 23 | Jul 17, 2026 | |
| MDT Medtronic | Reiterated: Buy | n/a | $90.77 | - | 8 | Jul 10, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $65 → $29 | $18.43 | +57.35% | 19 | Jun 12, 2026 | |
| SYK Stryker | Initiated Coverage: Buy | $410 | $275.09 | +49.04% | 1 | Apr 13, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiated Coverage: Hold | $101 | $93.98 | +7.47% | 1 | Apr 13, 2026 | |
| PEN Penumbra | Downgraded: Hold | $327 → $374 | $319.39 | +17.10% | 8 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 | $103.69 | +31.16% | 4 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.03 | - | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $84 | $89.53 | -6.18% | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 | $71.30 | +34.64% | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $29 | $17.50 | +65.71% | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $40.22 | +19.34% | 18 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $44.54 | n/a | 17 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $14.71 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $269.19 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,170.14 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $46 | $1.14 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $122.06 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $22.12 | n/a | 1 | Aug 15, 2022 |
Beta Bionics
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $27
Current: $22.81
Upside: +18.37%
Insulet
Aug 6, 2026
Downgraded: Hold
Price Target: $355 → $145
Current: $139.38
Upside: +4.03%
Boston Scientific
Jul 30, 2026
Reiterated: Buy
Price Target: $74 → $60
Current: $44.92
Upside: +33.57%
Edwards Lifesciences
Jul 24, 2026
Upgraded: Buy
Price Target: $87 → $101
Current: $88.78
Upside: +13.76%
Intuitive Surgical
Jul 17, 2026
Reiterated: Buy
Price Target: $600 → $454
Current: $402.09
Upside: +12.91%
Medtronic
Jul 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $90.77
Upside: -
PROCEPT BioRobotics
Jun 12, 2026
Downgraded: Hold
Price Target: $65 → $29
Current: $18.43
Upside: +57.35%
Stryker
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $410
Current: $275.09
Upside: +49.04%
Zimmer Biomet Holdings
Apr 13, 2026
Initiated Coverage: Hold
Price Target: $101
Current: $93.98
Upside: +7.47%
Penumbra
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $319.39
Upside: +17.10%
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $103.69
Upside: +31.16%
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $52.03
Upside: -
Oct 14, 2025
Reiterated: Buy
Price Target: $101 → $84
Current: $89.53
Upside: -6.18%
Oct 14, 2025
Reiterated: Hold
Price Target: $96
Current: $71.30
Upside: +34.64%
Oct 14, 2025
Reiterated: Buy
Price Target: $32 → $29
Current: $17.50
Upside: +65.71%
Oct 14, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $40.22
Upside: +19.34%
Aug 25, 2025
Reiterated: Buy
Price Target: $22
Current: $44.54
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $14.71
Upside: n/a
Apr 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $269.19
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: n/a
Current: $1,170.14
Upside: n/a
Sep 26, 2023
Reiterated: Buy
Price Target: $45 → $46
Current: $1.14
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $122.06
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $40
Current: $22.12
Upside: n/a